Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 10, 2010 - Issue 1
Submit an article Journal homepage
133
Views
25
CrossRef citations to date
0
Altmetric
Reviews

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

Ravi A Madan Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, Bethesda, MD 20892, USA
, MD,
Mahsa Mohebtash Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, Bethesda, MD 20892, USA
, MD,
Jeffrey Schlom Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, Bethesda, MD 20892, USA
, PhD &
James L Gulley Clinical Trials Group, Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA +1 301 435 2956; +1 301 480 5094; [email protected]
, PhD MD FACP
Pages 19-28 | Published online: 27 Oct 2009

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ravi A Madan, Jeanny B Aragon-Ching, James L Gulley & William L Dahut. (2011) From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Review of Vaccines 10:6, pages 743-753.
Read now
Ravi A Madan & James L Gulley. (2011) Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer. Expert Review of Vaccines 10:2, pages 141-150.
Read now

Articles from other publishers (23)

Brankica Filipić & Zorica Stojić-Vukanić. (2019) Active immunotherapy of cancer: An overview of therapeutic vaccines. Arhiv za farmaciju 69:6, pages 490-506.
Crossref
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy 153 160 .
Jeffrey Schlom, James W. Hodge, Claudia Palena, Kwong-Yok Tsang, Caroline Jochems, John W. Greiner, Benedetto Farsaci, Ravi A. Madan, Christopher R. Heery & James L. Gulley. 2014. 67 124 .
Jeffrey Schlom, Claudia Palena, James L. Gulley, John W. Greiner, Kwong-Yok Tsang, Ravi A. Madan & James W. Hodge. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer 315 334 .
Ravi A. Madan, Theresa A. Ferrara & James L. Gulley. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 553 568 .
Giuseppe Giaccone & Jean-Charles SoriaBenedetto Farsaci, Peter Kim, James Hodge, Claudia Palena, James Gulley & Jeffrey Schlom. 2013. Targeted Therapies in Oncology, Second Edition. Targeted Therapies in Oncology, Second Edition 341 366 .
James L. Gulley, Christopher R. Heery, Ravi A. Madan, Beatriz A. Walter, Maria J. Merino, William L. Dahut, Kwong-Yok Tsang, Jeffrey Schlom & Peter A. Pinto. (2013) Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunology, Immunotherapy 62:9, pages 1521-1531.
Crossref
Ravi A. Madan, James L. Gulley & Philip W. Kantoff. (2013) Demystifying Immunotherapy in Prostate Cancer. The Cancer Journal 19:1, pages 50-58.
Crossref
Jeffrey Schlom, James W. Hodge, Claudia Palena, John W. Greiner, Kwong-Yok Tsang, Benedetto Farsaci, Ravi A. Madan & James L. Gulley. 2013. Cancer Immunotherapy. Cancer Immunotherapy 309 331 .
Sandra Klein, Fiona M. Frame & Norman J. Maitland. 2013. Stem Cells: Current Challenges and New Directions. Stem Cells: Current Challenges and New Directions 279 300 .
Marijo Bilusic, Ravi A. Madan & James L. Gulley. 2013. Cancer Immunotherapy. Cancer Immunotherapy 455 474 .
Antonio T. Fojo & Anne Noonan. (2012) Why RECIST Works and Why It Should Stay—Counterpoint. Cancer Research 72:20, pages 5151-5157.
Crossref
Ravi A. Madan, Marijo Bilusic, Christopher Heery, Jeffrey Schlom & James L. Gulley. (2012) Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines. Seminars in Oncology 39:3, pages 296-304.
Crossref
J. Schlom. (2012) Therapeutic Cancer Vaccines: Current Status and Moving Forward. JNCI Journal of the National Cancer Institute 104:8, pages 599-613.
Crossref
Marijo Bilusic & James L. Gulley. (2011) Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines. Cancer Immunology, Immunotherapy 61:1, pages 109-117.
Crossref
Marijo Bilusic, Christopher Heery & Ravi A. Madan. (2011) Immunotherapy in prostate cancer: Emerging strategies against a formidable foe. Vaccine 29:38, pages 6485-6497.
Crossref
James L. Gulley & Charles G. Drake. (2011) Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research. Clinical Cancer Research 17:12, pages 3884-3891.
Crossref
. (2011) Current World Literature. Current Opinion in Urology 21:3, pages 257-264.
Crossref
Wilfred D. Stein, James L. Gulley, Jeff Schlom, Ravi A. Madan, William Dahut, William D. Figg, Yang-min Ning, Phil M. Arlen, Doug Price, Susan E. Bates & Tito Fojo. (2011) Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy. Clinical Cancer Research 17:4, pages 907-917.
Crossref
Anthony Koupparis, Rowan Casey, Michael Robinson & Martin E Gleave. (2010) Novel targeted agents on the horizon for castration-resistant prostate cancer. Future Oncology 6:12, pages 1883-1895.
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:3, pages 207-227.
Crossref
Julia Rotow, Sofia R. Gameiro, Ravi A. Madan, James L. Gulley, Jeffrey Schlom & James W. Hodge. (2010) Vaccines as Monotherapy and in Combination Therapy for Prostate Cancer. Clinical and Translational Science 3:3, pages 116-122.
Crossref
Yalong Zhang, Christopher Campbell, Qian Li & Jeffrey C. Gildersleeve. (2010) Multidimensional glycan arrays for enhanced antibody profiling. Molecular BioSystems 6:9, pages 1583.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.